Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Sara Sheikhbahaei

Dados Biográficos

ID7186236
NOMESara Sheikhbahaei
PRENOMESSara
SOBRENOMESheikhbahaei
ASSINATURASHEIKHBAHAEI S
AFILIAÇÕESTehran University of Medical Sciences
ORCID0000-0001-7866-4681
VERIFICADOSim
TOTAL DE OBRAS20
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR20
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2014
ANO MAIS RECENTE DE PUBLICAÇÃO2022
ÍNDICE H0
  • Population-level risks of alcohol consumption by amount, geography, age, sex, and year

    Open Access•Dana Bryazka, Marissa B Reitsma et al.•ARTICLE•The Lancet•2022

    BACKGROUND: The health risks associated with moderate alcohol consumption continue to be debated. Small amounts of alcohol might lower the risk of some health outcomes but increase the risk of others, suggesting that the overall risk depends, in part, on background disease rates, which vary by region, age, sex, and year. METHODS: For this analysis, we constructed burden-weighted dose-response relative risk curves across 22 health outcomes to esti…

  • Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019

    Open Access•Global Burden of Disease Cancer Collaboration, Jonathan Kocarnik et al.•ARTICLE•JAMA Oncology•2022

    IMPORTANCE: The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. OBJECTIVE: To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. EVIDENCE REVIEW: The GBD 2019 estimation methods were used t…

  • Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health

    Open Access•Katherine R Paulson, Katherine Paulson et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, a…

  • Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019

    Open Access•Marissa B Reitsma, Parkes J Kendrick et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. METHODS: We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global B…

  • Global, regional, and national burden of stroke and its risk factors, 1990–2019

    Open Access•Valery L Feigin, Benjamin A Stark et al.•ARTICLE•The Lancet Neurology•2021

    BACKGROUND: Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national leve…

  • Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015

    Open Access•Ryan M Barber, Nancy Fullman et al.•ARTICLE•The Lancet•2017

    BACKGROUND: National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality). Previous analyses of mortality amenable to health care only focused on high-income countries and faced several methodological challenges. In the present analysis, we use the highly standardised cause of death and risk factor …

  • Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016

    Open Access•Mohsen Naghavi, Amanuel Alemu Abajobir et al.•ARTICLE•The Lancet•2017

    BACKGROUND: Monitoring levels and trends in premature mortality is crucial to understanding how societies can address prominent sources of early death. The Global Burden of Disease 2016 Study (GBD 2016) provides a comprehensive assessment of cause-specific mortality for 264 causes in 195 locations from 1980 to 2016. This assessment includes evaluation of the expected epidemiological transition with changes in development and where local patterns …

  • Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015

    Open Access•Haidong Wang, Zulfiqar A Bhutta et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Established in 2000, Millennium Development Goal 4 (MDG4) catalysed extraordinary political, financial, and social commitments to reduce under-5 mortality by two-thirds between 1990 and 2015. At the country level, the pace of progress in improving child survival has varied markedly, highlighting a crucial need to further examine potential drivers of accelerated or slowed decreases in child mortality. The Global Burden of Disease 2015 …

  • Global, regional, and national disability-adjusted life-years (Dalys) for 315 diseases and injuries and healthy life expectancy (Hale), 1990–2015

    Open Access•Nicholas J Kassebaum, Megha Arora et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Healthy life expectancy (HALE) and disability-adjusted life-years (DALYs) provide summary measures of health across geographies and time that can inform assessments of epidemiological patterns and health system performance, help to prioritise investments in research and development, and monitor progress toward the Sustainable Development Goals (SDGs). We aimed to provide updated HALE and DALYs for geographies worldwide and evaluate ho…

  • Global, regional, and national levels of maternal mortality, 1990–2015

    Open Access•Nicholas J Kassebaum, Ryan M Barber et al.•ARTICLE•The Lancet•2016

    BACKGROUND: In transitioning from the Millennium Development Goal to the Sustainable Development Goal era, it is imperative to comprehensively assess progress toward reducing maternal mortality to identify areas of success, remaining challenges, and frame policy discussions. We aimed to quantify maternal mortality throughout the world by underlying cause and age from 1990 to 2015. METHODS: We estimated maternal mortality at the global, regional, …

  • Measuring the health-related Sustainable Development Goals in 188 countries

    Open Access•Stephen S Lim, Kate Allen et al.•ARTICLE•The Lancet•2016

    BACKGROUND: In September, 2015, the UN General Assembly established the Sustainable Development Goals (SDGs). The SDGs specify 17 universal goals, 169 targets, and 230 indicators leading up to 2030. We provide an analysis of 33 health-related SDG indicators based on the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015). METHODS: We applied statistical methods to systematically compiled data to estimate the performance of…

  • Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015

    Open Access•Haidong Wang, Mohsen Naghavi et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015. These results informed an in-depth investigation of observed and expected mortality patterns bas…

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015

    Open Access•Mohammad H Forouzanfar, Ashkan Afshin et al.•ARTICLE•The Lancet•2016

    BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden of disease. By providing national and subnational assessments spanning the past 25 years, this study can inform debates on the importance of addressing risks in context. METHODS: We used the comparative risk assessment framework developed for previous iterations of t…

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013

    Open Access•Mohammad H Forouzanfar, Lily Alexander et al.•ARTICLE•The Lancet•2015

  • Global, regional, and national disability-adjusted life years (Dalys) for 306 diseases and injuries and healthy life expectancy (Hale) for 188 countries, 1990–2013

    Open Access•Christopher J L Murray, Ryan M Barber et al.•ARTICLE•The Lancet•2015

  • Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013

    Open Access•Theo Vos, Ryan M Barber et al.•ARTICLE•The Lancet•2015

  • Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013

    Open Access•Christopher J L Murray, Katrina F Ortblad et al.•ARTICLE•The Lancet•2014

  • Global, regional, and national levels and causes of maternal mortality during 1990–2013

    Open Access•Nicholas J Kassebaum, Amelia Bertozzi-Villa et al.•ARTICLE•The Lancet•2014

  • Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013

    Open Access•Haidong Wang, Chelsea A Liddell et al.•ARTICLE•The Lancet•2014

    BACKGROUND: Remarkable financial and political efforts have been focused on the reduction of child mortality during the past few decades. Timely measurements of levels and trends in under-5 mortality are important to assess progress towards the Millennium Development Goal 4 (MDG 4) target of reduction of child mortality by two thirds from 1990 to 2015, and to identify models of success. METHODS: We generated updated estimates of child mortality i…

  • Revising the fasting glucose threshold for detection of cardiovascular risk factors

    Open Access•Alireza Esteghamati, Ali Zandieh et al.•ARTICLE•Annals of Human Biology•2014

    IFG and even lower levels of FPG are associated with high prevalence of cardiovascular risk factors in Iranian adults. This study suggests the FPG cut-off to be revised at 90 mg/dL to identify people with increased cardiovascular risk

Sem obras proeminentes nesta página.

  • Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013

    Open Access•Christopher J L Murray, Katrina F Ortblad et al.•ARTICLE•The Lancet•2014

  • Global, regional, and national levels and causes of maternal mortality during 1990–2013

    Open Access•Nicholas J Kassebaum, Amelia Bertozzi-Villa et al.•ARTICLE•The Lancet•2014

  • Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013

    Open Access•Haidong Wang, Chelsea A Liddell et al.•ARTICLE•The Lancet•2014

    BACKGROUND: Remarkable financial and political efforts have been focused on the reduction of child mortality during the past few decades. Timely measurements of levels and trends in under-5 mortality are important to assess progress towards the Millennium Development Goal 4 (MDG 4) target of reduction of child mortality by two thirds from 1990 to 2015, and to identify models of success. METHODS: We generated updated estimates of child mortality i…

  • Revising the fasting glucose threshold for detection of cardiovascular risk factors

    Open Access•Alireza Esteghamati, Ali Zandieh et al.•ARTICLE•Annals of Human Biology•2014

    IFG and even lower levels of FPG are associated with high prevalence of cardiovascular risk factors in Iranian adults. This study suggests the FPG cut-off to be revised at 90 mg/dL to identify people with increased cardiovascular risk

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013

    Open Access•Mohammad H Forouzanfar, Lily Alexander et al.•ARTICLE•The Lancet•2015

  • Global, regional, and national disability-adjusted life years (Dalys) for 306 diseases and injuries and healthy life expectancy (Hale) for 188 countries, 1990–2013

    Open Access•Christopher J L Murray, Ryan M Barber et al.•ARTICLE•The Lancet•2015

  • Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013

    Open Access•Theo Vos, Ryan M Barber et al.•ARTICLE•The Lancet•2015

  • Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015

    Open Access•Haidong Wang, Zulfiqar A Bhutta et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Established in 2000, Millennium Development Goal 4 (MDG4) catalysed extraordinary political, financial, and social commitments to reduce under-5 mortality by two-thirds between 1990 and 2015. At the country level, the pace of progress in improving child survival has varied markedly, highlighting a crucial need to further examine potential drivers of accelerated or slowed decreases in child mortality. The Global Burden of Disease 2015 …

  • Global, regional, and national disability-adjusted life-years (Dalys) for 315 diseases and injuries and healthy life expectancy (Hale), 1990–2015

    Open Access•Nicholas J Kassebaum, Megha Arora et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Healthy life expectancy (HALE) and disability-adjusted life-years (DALYs) provide summary measures of health across geographies and time that can inform assessments of epidemiological patterns and health system performance, help to prioritise investments in research and development, and monitor progress toward the Sustainable Development Goals (SDGs). We aimed to provide updated HALE and DALYs for geographies worldwide and evaluate ho…

  • Global, regional, and national levels of maternal mortality, 1990–2015

    Open Access•Nicholas J Kassebaum, Ryan M Barber et al.•ARTICLE•The Lancet•2016

    BACKGROUND: In transitioning from the Millennium Development Goal to the Sustainable Development Goal era, it is imperative to comprehensively assess progress toward reducing maternal mortality to identify areas of success, remaining challenges, and frame policy discussions. We aimed to quantify maternal mortality throughout the world by underlying cause and age from 1990 to 2015. METHODS: We estimated maternal mortality at the global, regional, …

  • Measuring the health-related Sustainable Development Goals in 188 countries

    Open Access•Stephen S Lim, Kate Allen et al.•ARTICLE•The Lancet•2016

    BACKGROUND: In September, 2015, the UN General Assembly established the Sustainable Development Goals (SDGs). The SDGs specify 17 universal goals, 169 targets, and 230 indicators leading up to 2030. We provide an analysis of 33 health-related SDG indicators based on the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015). METHODS: We applied statistical methods to systematically compiled data to estimate the performance of…

  • Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015

    Open Access•Haidong Wang, Mohsen Naghavi et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015. These results informed an in-depth investigation of observed and expected mortality patterns bas…

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015

    Open Access•Mohammad H Forouzanfar, Ashkan Afshin et al.•ARTICLE•The Lancet•2016

    BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden of disease. By providing national and subnational assessments spanning the past 25 years, this study can inform debates on the importance of addressing risks in context. METHODS: We used the comparative risk assessment framework developed for previous iterations of t…

  • Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015

    Open Access•Ryan M Barber, Nancy Fullman et al.•ARTICLE•The Lancet•2017

    BACKGROUND: National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality). Previous analyses of mortality amenable to health care only focused on high-income countries and faced several methodological challenges. In the present analysis, we use the highly standardised cause of death and risk factor …

  • Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016

    Open Access•Mohsen Naghavi, Amanuel Alemu Abajobir et al.•ARTICLE•The Lancet•2017

    BACKGROUND: Monitoring levels and trends in premature mortality is crucial to understanding how societies can address prominent sources of early death. The Global Burden of Disease 2016 Study (GBD 2016) provides a comprehensive assessment of cause-specific mortality for 264 causes in 195 locations from 1980 to 2016. This assessment includes evaluation of the expected epidemiological transition with changes in development and where local patterns …

  • Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health

    Open Access•Katherine R Paulson, Katherine Paulson et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, a…

  • Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019

    Open Access•Marissa B Reitsma, Parkes J Kendrick et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. METHODS: We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global B…

  • Global, regional, and national burden of stroke and its risk factors, 1990–2019

    Open Access•Valery L Feigin, Benjamin A Stark et al.•ARTICLE•The Lancet Neurology•2021

    BACKGROUND: Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national leve…

  • Population-level risks of alcohol consumption by amount, geography, age, sex, and year

    Open Access•Dana Bryazka, Marissa B Reitsma et al.•ARTICLE•The Lancet•2022

    BACKGROUND: The health risks associated with moderate alcohol consumption continue to be debated. Small amounts of alcohol might lower the risk of some health outcomes but increase the risk of others, suggesting that the overall risk depends, in part, on background disease rates, which vary by region, age, sex, and year. METHODS: For this analysis, we constructed burden-weighted dose-response relative risk curves across 22 health outcomes to esti…

  • Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019

    Open Access•Global Burden of Disease Cancer Collaboration, Jonathan Kocarnik et al.•ARTICLE•JAMA Oncology•2022

    IMPORTANCE: The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. OBJECTIVE: To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. EVIDENCE REVIEW: The GBD 2019 estimation methods were used t…

Environmental health (20 obras) · Medicine (20 obras) · Population (14 obras) · Burden of disease (13 obras) · Demography (13 obras) · Disease (11 obras) · Global Maternal and Child Health (11 obras) · Disease burden (8 obras) · Internal Medicine (8 obras) · Global health (7 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae